Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

FNCH Finch Therapeutics Group, Inc. Common Stock
$13.65 0.00% 0.00
Notify me if price changes either direction
Interactive Brokers Logotype

Buy FNCH stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 22.0M
Enterprise value 34.9M
Trailing PE -0.29405451404304
Forward PE -0.66537154
PEG Ratio 0.0096458791348966
Enterprise to EBITDA -1.787
Enterprise to revenue 325.85271028037
Price to book MRQ 1.5471486
Price to sales TTM 205.59781308411

Financials

Fiscal Year Ends 2023-12-31
Most Recent Quarter (MRQ) 2024-06-30
Revenue (TTM) 107.0K
EBITDA 17.4M
Diluted EPS TTM -8.8
Total Cash (MRQ) 16.0M
Current ratio (MRQ) 3.872
Operating Cash Flow (TTM) -18055000

FNCH trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent FNCH News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.